ALAB.NASDAQAstera Labs, INC

DEF: Astera Labs Sets Date for 2025 Annual Stockholders Meeting

Sentiment:

Proxy Statement


Astera Labs will hold its 2025 Annual Meeting of Stockholders on June 5, 2025, to elect directors and ratify the appointment of its independent accounting firm.

Summary

  • Astera Labs will hold its 2025 Annual Meeting of Stockholders on June 5, 2025, at 10:00 a.m. Pacific Time at the offices of Goodwin Procter LLP in Redwood City, California.
  • The purposes of the meeting include the election of three Class I directors to serve until the 2028 Annual Meeting, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and the transaction of any other business properly brought before the meeting.
  • Stockholders of record as of April 15, 2025, are entitled to vote at the Annual Meeting.
  • The company is providing access to proxy materials over the Internet, with a Notice of Internet Availability of Proxy Materials mailed to stockholders around April 24, 2025.
  • Stockholders can vote by proxy over the Internet, by telephone, or by mail, with specific deadlines for each method.
  • The board of directors recommends voting for the election of Jitendra Mohan, Stefan Dyckerhoff, and Bethany Mayer as Class I directors and for the ratification of PricewaterhouseCoopers LLP as the independent accounting firm.
  • The proxy statement includes information on corporate governance, director compensation, executive compensation, related person transactions, and principal stockholders.
  • The company's board consists of eight members divided into three classes with staggered three-year terms.
  • The company has established an audit committee, a compensation committee, and a nominating and corporate governance committee.
  • The company has adopted a code of business conduct and ethics, an insider trading policy, and a performance-based compensation recovery policy.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, outlining the details of the upcoming annual meeting and related corporate governance matters. The sentiment is neutral to slightly positive due to the routine nature of the announcements and the company's adherence to corporate governance best practices.

Positives

  • The board of directors is actively engaged in corporate governance, with established committees and policies.
  • The company provides stockholders with the ability to communicate with the board of directors.
  • The company has adopted policies to ensure ethical conduct and compliance with regulations, including an insider trading policy and a compensation recovery policy.
  • The company is committed to aligning executive compensation with long-term stockholder value.
  • The company has a Change of Control Severance Policy for Principal Executive Officers.

Risks

  • The document includes forward-looking statements that are subject to risks and uncertainties, as detailed in the company's 2024 Annual Report on Form 10-K.
  • The limitation of liability and indemnification provisions in the company's charter and bylaws may discourage lawsuits against directors and executive officers.

Future Outlook

The document does not provide specific forward-looking financial guidance, but it references the company's plans and goals, which are subject to risks and uncertainties detailed in the 2024 Annual Report on Form 10-K.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors.

Related Party Transactions

  • The company is party to an amended and restated investors rights agreement with certain stockholders, including entities affiliated with Sutter Hill Ventures and Fidelity Management and Research.
  • The company has granted stock options and RSUs to its executive officers and certain of its directors.

Stakeholder Impact

  • Stockholders have the opportunity to vote on important matters related to the company's governance and direction.
  • The election of directors and ratification of the accounting firm are important for maintaining investor confidence.
  • The company's compensation policies impact executive motivation and retention.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting on June 5, 2025.
  • The company will file a Current Report on Form 8-K with the SEC to announce the final voting results.

Key Dates

DateDescription
March 13, 2018Offer letters to Jitendra Mohan and Sanjay Gajendra
July 21, 2020Employment agreement with Michael Tate
May 17, 2022Amended and restated investors rights agreement
August 23, 2022Mike Tate received restricted stock units
August 2023Change of Control Severance Policy for Principal Executive Officers adopted
August 9, 2023Mike Tate received restricted stock units
January 24, 2024Jitendra Mohan, Sanjay Gajendra, and Mike Tate received restricted stock units
February 1, 2024Annual base salary increases for Jitendra Mohan, Sanjay Gajendra, and Michael Tate
February 7, 2024Mike Tate received restricted stock units
March 2024Nominating and corporate governance committee formed
March 20, 2024First offering period under the 2024 ESPP commenced
June 2024Bethany Mayer joined the board of directors
August 13, 2024Mike Tate received restricted stock units
November 12, 2024Schedule 13G/A filed by FMR LLC
December 31, 2024End of fiscal year
January 30, 2025Schedule 13G filed by the Vanguard Group
March 1, 2025Date for principal stockholders information
April 15, 2025Record Date for Annual Meeting
April 24, 2025Intended mailing date of Notice of Internet Availability of Proxy Materials
April 24, 2025Audit Committee Report Date
May 22, 2025Deadline to request a paper package in time for the Annual Meeting
June 4, 2025Proxy submission deadline (Internet or telephone)
June 5, 20252025 Annual Meeting of Stockholders
December 25, 2025Deadline for stockholder proposals for the 2026 annual meeting
February 5, 2026Earliest date for stockholder proposals to be brought before the 2026 annual meeting
March 7, 2026Latest date for stockholder proposals to be brought before the 2026 annual meeting
April 6, 2026Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees other than the Company's nominees

Keywords

Annual Meeting, Proxy Statement, Directors, Stockholders, Corporate Governance, Executive Compensation, Astera Labs

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.